TRAM Snapshot of App at Pub for Oppostn

XCOPRI

SK BIOPHARMACEUTICALS CO., LTD.

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88484180 FILING DATE 06/21/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY SHERMAN, SAMANTHA LEIG
L.O. ASSIGNED N50-NOT FOUND

PUB INFORMATION

RUN DATE 01/03/2020
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 01/02/2020
LITERAL MARK ELEMENT XCOPRI

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT XCOPRI
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG YES

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME SK BIOPHARMACEUTICALS CO., LTD.
ADDRESS 221, Pangyoyeok-ro, Bundang-gu
Seongnam-si, 13494
ENTITY 03-CORPORATION
CITIZENSHIP Republic of Korea

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT The colors purple and red are claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of the stylized word "XCOPRI" in purple upper case letters. The letter "O" contains a red circular design divided by a triangular ray, which extends past the letter "O". The remaining color white represents background and is not a feature of the mark.

FOREIGN INFORMATION

PRIORITY CLAIMED SEC. 44(D) ON Republic of Korea
APPLICATION NO. 40-2019-0096
APPLICATION FILING DATE 06/21/2019
FOREIGN REG NO. N/A
FOREIGN REG DATE N/A
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION N/A
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/02/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 014
12/23/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 013
12/23/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 012
12/11/2019 ALIE A ASSIGNED TO LIE 011
12/06/2019 ALIE A ASSIGNED TO LIE 010
11/27/2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED 009
10/07/2019 DOCK D ASSIGNED TO EXAMINER 008
09/16/2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED 007
09/16/2019 GNSL F LETTER OF SUSPENSION E-MAILED 006
09/16/2019 CNSL R SUSPENSION LETTER WRITTEN 005
09/12/2019 DOCK D ASSIGNED TO EXAMINER 004
07/03/2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
07/02/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
06/25/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Diane J. Mason
CORRESPONDENCE ADDRESS Diane J. Mason
DRINKER BIDDLE & REATH LLP
Four Embarcadero Center, 27th Floor
San Francisco, CA, 94111
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed